MX2017008454A - Peptidos y su uso en el tratamiento de la piel. - Google Patents

Peptidos y su uso en el tratamiento de la piel.

Info

Publication number
MX2017008454A
MX2017008454A MX2017008454A MX2017008454A MX2017008454A MX 2017008454 A MX2017008454 A MX 2017008454A MX 2017008454 A MX2017008454 A MX 2017008454A MX 2017008454 A MX2017008454 A MX 2017008454A MX 2017008454 A MX2017008454 A MX 2017008454A
Authority
MX
Mexico
Prior art keywords
peptides
skin
treatment
compositions
growth
Prior art date
Application number
MX2017008454A
Other languages
English (en)
Inventor
Santhanam Uma
Idkowiak Baldys Jolanta
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of MX2017008454A publication Critical patent/MX2017008454A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)

Abstract

Realizaciones de la invención se refieren generalmente a los métodos de disminuir los signos de envejecimiento en y/o mejorar la salud de integumentos humanos tales como la piel, y a composiciones que comprenden péptidos útiles para ello. Las composiciones de acuerdo con la invención pueden comprender uno o más péptidos o fragmentos o derivados de los mismos derivados de un factor de crecimiento, p. ej., Factor de Diferenciación de Crecimiento 11 (GDF11) en un vehículo tópicamente aceptable.
MX2017008454A 2014-12-23 2015-09-03 Peptidos y su uso en el tratamiento de la piel. MX2017008454A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462095873P 2014-12-23 2014-12-23
PCT/US2015/048240 WO2016105607A1 (en) 2014-12-23 2015-09-03 Peptides and their use in the treatment of skin

Publications (1)

Publication Number Publication Date
MX2017008454A true MX2017008454A (es) 2017-10-31

Family

ID=56128191

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008454A MX2017008454A (es) 2014-12-23 2015-09-03 Peptidos y su uso en el tratamiento de la piel.

Country Status (10)

Country Link
US (1) US10034826B2 (es)
EP (1) EP3236992A4 (es)
CN (1) CN107106652A (es)
BR (1) BR112017013696B1 (es)
CA (1) CA2972015A1 (es)
MX (1) MX2017008454A (es)
PH (1) PH12017501070A1 (es)
RU (1) RU2709778C2 (es)
WO (1) WO2016105607A1 (es)
ZA (1) ZA201704726B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101810385B1 (ko) * 2016-02-04 2017-12-20 주식회사 강스템바이오텍 Gdf11을 포함하는 조성물 및 그의 용도
US10758559B1 (en) 2017-09-01 2020-09-01 University Of Wyoming Targeting cathepsin K to facilitate wound healing
US11766467B2 (en) 2017-09-01 2023-09-26 University Of Wyoming Methods of treating wounds using cathepsin K inhibitors
CN111093687B (zh) * 2017-09-15 2024-07-09 凯恩塞恩斯株式会社 作为自身免疫疾病及骨病治疗剂的肽的用途
CN108586575B (zh) * 2018-04-11 2020-08-14 福建省中科生物股份有限公司 一种多肽及其皮肤修复功能的应用
BR112021013164B1 (pt) 2019-01-04 2023-10-17 Avon Products, Inc Composição tópica compreendendo derivados oxidados de fragmentos de gdf-11 e método não terapêutico para diminuir o aparecimento de sinais dermatológicos de envelhecimento
US20220273765A1 (en) * 2019-04-24 2022-09-01 Follicum Ab Topical formulation
WO2022051831A1 (pt) * 2020-09-11 2022-03-17 Chemyunion Ltda. Composição, uso de composição, método cosmético e método para modular a produção de sebo

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
US20030167492A1 (en) 1994-07-08 2003-09-04 Johns Hopkins University School Of Medicine Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
WO2001046220A2 (en) * 1999-12-22 2001-06-28 Polymun Scientific Immunbiologische Forschung Gmbh Bioactive oligopeptides
CA2462791A1 (en) 2001-10-05 2003-04-17 Procyte Corporation Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof
JP2005533855A (ja) 2002-07-24 2005-11-10 インターツェル・アクチェンゲゼルシャフト 病原性ウイルスからの別のリーディングフレームによりコードされる抗原
AU2003292326A1 (en) * 2002-11-08 2004-06-03 Societe D'extraction Des Principes Actifs (Vincience) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
US7141544B2 (en) * 2003-10-10 2006-11-28 Baxter International, Inc. Stabilization of pharmaceutical protein formulations with small peptides
WO2005120554A1 (en) * 2004-06-14 2005-12-22 Cognis France S.A.S. Cosmetic preparations containing pth fragments
TWI415628B (zh) 2006-02-28 2013-11-21 Avon Prod Inc 包含具有非天然胺基酸之胜肽之組合物及其使用方法
ES2402672T3 (es) * 2007-01-25 2013-05-07 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Uso del GDF-5 para el mejoramiento o el mantenimiento del aspecto dérmico
US8987212B2 (en) 2007-08-07 2015-03-24 Muhammed Majeed Oleanoyl peptide composition and method of treating skin aging
US20110027209A1 (en) * 2008-04-08 2011-02-03 Merck Patent Gesellschaft Compositions Containing Cyclic Peptides And Methods Of Use
EP2454368A4 (en) * 2009-07-17 2013-01-09 Aaron Thomas Tabor COMPOSITIONS AND METHOD FOR THE GENETIC MODIFICATION OF COSMETIC FUNCTION CELLS FOR IMPROVING THE COSMETIC APPEARANCE PICTURE
WO2011063165A1 (en) * 2009-11-18 2011-05-26 Affinergy, Inc. Methods and compositions for capture of cells
EP3042665A1 (en) * 2009-12-28 2016-07-13 N.V. Perricone LLC Cosmetic method for improving the signs of skin aging by using a topical acyl glutathione formulation
CN101884602A (zh) * 2010-03-03 2010-11-17 孙杰 一种皮肤美容修复抗衰除皱的化妆品制剂
KR20130052441A (ko) * 2011-11-11 2013-05-22 (주) 코웰메디 재조합 인간 골형성 단백질과 트위스트 전사인자를 활성성분으로 함유하는 피부조직 재생용 조성물 및 키트
EP2833923A4 (en) 2012-04-02 2016-02-24 Moderna Therapeutics Inc MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
FR2998570B1 (fr) * 2012-11-26 2016-12-02 Sederma Sa Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
EP2970382B1 (en) * 2013-03-13 2019-09-25 Anteis SA Peptides for skin rejuvenation and methods of using the same
KR20150133222A (ko) * 2013-03-13 2015-11-27 스테메트릭스, 인코포레이티드. 피부 조성물 및 피부 조성물의 용도
ITRM20130199A1 (it) 2013-04-03 2014-10-04 Irbm Science Park S P A Peptidi per uso dermatologico e/o cosmetico
US10092627B2 (en) * 2013-04-08 2018-10-09 President And Fellows Of Harvard College Methods and compositions for rejuvenating skeletal muscle stem cells
US9125843B2 (en) * 2013-10-03 2015-09-08 Elc Management Llc Methods and compositions for improving the appearance of skin
EP3236981A1 (en) * 2014-12-23 2017-11-01 Avon Products, Inc. Peptides and their use in the treatment of skin
EP3236982A1 (en) * 2014-12-23 2017-11-01 Avon Products, Inc. Peptides and their use in the treatment of skin
EP3236980A1 (en) * 2014-12-23 2017-11-01 Avon Products, Inc. Peptides and their use in the treatment of skin
US9597274B2 (en) * 2015-06-17 2017-03-21 Avon Products, Inc. Peptides and their use in the treatment of skin

Also Published As

Publication number Publication date
RU2709778C2 (ru) 2019-12-20
EP3236992A1 (en) 2017-11-01
WO2016105607A1 (en) 2016-06-30
CA2972015A1 (en) 2016-06-30
BR112017013696A2 (pt) 2018-02-06
RU2017123388A3 (es) 2019-01-25
PH12017501070A1 (en) 2017-12-11
US20160175225A1 (en) 2016-06-23
BR112017013696B1 (pt) 2024-01-02
CN107106652A (zh) 2017-08-29
EP3236992A4 (en) 2018-09-05
US10034826B2 (en) 2018-07-31
ZA201704726B (en) 2019-01-30
RU2017123388A (ru) 2019-01-24

Similar Documents

Publication Publication Date Title
PH12017501070A1 (en) Peptides and their use in the treatment of skin
ZA201905488B (en) Tigit- and light-based chimeric proteins
MX2022005291A (es) Vacunas para el tratamiento y prevencion del cancer.
MX2017013562A (es) Reguladores de microbioma y usos relacionados de los mismos.
WO2017095944A8 (en) Methods and compositions relating to chondrisomes from blood products
MX2019015311A (es) Composiciones de ésteres de ácido cannabidiólico y usos de las mismas.
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
MX2017001279A (es) Usos y composiciones de la flagelina.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
PH12019502036A1 (en) Peptides and methods for the treatment of diabetes
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
PH12019550265A1 (en) Composition comprising mannose oligosaccharide and process for making same and use thereof
MX2018000570A (es) Nuevas isoformas de tripsina y su uso.
PH12019502469A1 (en) Novel fragrance compositions and products with mood enhancing effects
MX2017012595A (es) Un extracto de indigo naturalis y un proceso para preparar el mismo.
WO2016149659A3 (en) Antisense-induced exon exclusion in myostatin
WO2015191449A3 (en) Personal care products containing microalgae or extracts thereof
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
ZA201802606B (en) Compositions for dental varnishes and methods of making and using same
WO2016094374A8 (en) Compositions and methods for treatment of friedreich's ataxia
MX2017013819A (es) Metodos para la reduccion de grasa.
SG10201805890QA (en) Compositions and methods for treatment of abnormal cell growth
MX2018007468A (es) Composiciones de colageno 7 y metodos para usar las mismas.
MX2015001648A (es) Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos.
MX2017003949A (es) Derivados peptidicos novedosos y sus usos.